Abstract
This review article provides a systematic overview of the currently available evidence on the clinical effectiveness of particle therapy for the treatment of non-small cell lung cancer and summarizes findings of in silico comparative planning studies. Furthermore, technical issues and dosimetric uncertainties with respect to thoracic particle therapy are discussed.
Original language | English |
---|---|
Article number | 292 |
Journal | Frontiers in Oncology |
Volume | 4 |
DOIs | |
Publication status | Published - 2014 |